News2 mins ago
Visgenx to present at the American Society of Gene and Cell Therapy 2023 Annual Meeting
Poster presentation covers data on VGX-0111, the Company’s gene therapy candidate for Dry Age-related Macular Degeneration (AMD), an aging related disorder and a leading cause of...
